How myLoop supports pregnancy
Tanya has been living with type 1 diabetes for over 20 years. During her pregnancy, she began using myLoop. During this special yet stressful time, it was important for Tanya to listen to her body and to find a therapy which suited her. She appreciates the fact that during a rather difficult pregnancy, the diabetes aspect was made easy. This was one aspect that she did not need to worry about because she knew she was being supported.
Helpful support – before, during and after pregnancy
Tanya's advice for women who want to become pregnant:
There is a lot to consider during pregnancy. Before the hybrid closed-loop system, Tanya had still quite a bit of control, but she did not realise how much time it takes to think about diabetes and its treatment.
Once she started trusting myLoop, she felt as though she had a weight lifted off her shoulders and it profoundly lessened her mental load.The support of myLoop does not stop once the baby is born. The ability to have a system that works for as she focused on her baby was a huge support. She felt as though someone had her back. Whenever a bolus is forgotten, the algorithm jumps in and covers what she previously had to do herself.
In addition, myLoop also supported Tanya when breastfeeding:
Disclaimer
* Approved for people with type 1 diabetes as of two years in combination with Dexcom G6 and four years in combination with FreeStyle Libre 3.The product images are for illustrative purposes only.
mylife and YpsoPump are registered trademarks of Ypsomed AG in several countries.
CamAPS is a registered trademark of CamDiab Ltd.
Dexcom and Dexcom G6 are registered trademarks of Dexcom, Inc. in the United States and/or other countries.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ypsomed is under license.Other trademarks are the property of their respective owners.
mylife Loop with Freestyle Libre3/Libre 3 Plus: The innovations described are available in selected countries and expanding to further countries soon. Expansion is contingent upon local regulatory approval.Insulin pumps and Automated Insulin Delivery (AID) systems can improve glucose management but do not remove the risk of diabetic ketoacidosis (DKA). Because these systems use only rapid-acting insulin, any interruption in insulin delivery (e.g., infusion-set failure, occlusion, empty reservoir, or device malfunction) can rapidly lead to ketosis and DKA, even if glucose levels are not markedly elevated.
Healthcare professionals should ensure that users understand the risk of DKA associated with pump and AID therapy, particularly in situations where insulin delivery may be interrupted. Users should be trained to recognise and troubleshoot delivery issues promptly, know when and how to check for ketones and seek urgent medical assistance. Advise to always keep a reliable backup method of insulin delivery available.This information is provided for general educational purposes and is intended for healthcare professionals. It does not replace individual clinical judgement or patient-specific medical advice.